117 related articles for article (PubMed ID: 35822545)
1. Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series.
Chang A; Mitchell J; Alejo JL; Chiang TPY; Abedon AT; Kim JD; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Massie AB; Segev DL; Werbel WA
Clin Transplant; 2022 Sep; 36(9):e14772. PubMed ID: 35822545
[No Abstract] [Full Text] [Related]
2. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.
Chang A; Alejo JL; Abedon AT; Mitchell J; Chiang TP; Boyarsky BJ; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
Transplantation; 2022 Feb; 106(2):e161-e162. PubMed ID: 34789691
[No Abstract] [Full Text] [Related]
3. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
Chiang TP; Alejo JL; Mitchell J; Kim JD; Abedon AT; Karaba AH; Thomas L; Levan ML; Garonzik-Wang JM; Avery RK; Pekosz A; Clarke WA; Warren DS; Tobian AAR; Massie AB; Segev DL; Werbel WA
Am J Transplant; 2022 Sep; 22(9):2254-2260. PubMed ID: 35429211
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
[No Abstract] [Full Text] [Related]
7. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
[No Abstract] [Full Text] [Related]
9. Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
Naranbhai V; Garcia-Beltran WF; Chang CC; Berrios Mairena C; Thierauf JC; Kirkpatrick G; Onozato ML; Cheng J; St Denis KJ; Lam EC; Kaseke C; Tano-Menka R; Yang D; Pavlovic M; Yang W; Kui A; Miller TE; Astudillo MG; Cahill JE; Dighe AS; Gregory DJ; Poznansky MC; Gaiha GD; Balazs AB; Iafrate AJ
J Infect Dis; 2022 Apr; 225(7):1141-1150. PubMed ID: 34888672
[TBL] [Abstract][Full Text] [Related]
10. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
[TBL] [Abstract][Full Text] [Related]
11. Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Abedon AT; Alejo JL; Kim JD; Thomas L; Mitchell J; Chiang TPY; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
Transplantation; 2022 May; 106(5):e281-e283. PubMed ID: 35066543
[No Abstract] [Full Text] [Related]
12. Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
Tada T; Zhou H; Samanovic MI; Dcosta BM; Cornelius A; Herati RS; Mulligan MJ; Landau NR
Front Immunol; 2022; 13():797589. PubMed ID: 35350781
[TBL] [Abstract][Full Text] [Related]
13. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.
Ravanan R; Mumford L; Ushiro-Lumb I; Callaghan C; Pettigrew G; Thorburn D; Gardiner D; Forsythe J;
Transplantation; 2021 Nov; 105(11):e263-e264. PubMed ID: 34310530
[No Abstract] [Full Text] [Related]
14. Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers.
Brunner WM; Freilich D; Victory J; Krupa N; Scribani MB; Jenkins P; Lasher EG; Fink A; Shah A; Cross P; Bush V; Peek LJ; Pestano GA; Gadomski AM
Int J Infect Dis; 2022 Oct; 123():183-191. PubMed ID: 36044963
[TBL] [Abstract][Full Text] [Related]
15. 6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients.
Mitchell J; Chiang TP; Alejo JL; Kim JD; Chang A; Abedon AT; Avery RK; Tobian AAR; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Massie AB; Werbel WA
Clin Transplant; 2023 Jan; 37(1):e14868. PubMed ID: 36437691
[No Abstract] [Full Text] [Related]
16. Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.
Khoo NKH; Lim JME; Gill US; de Alwis R; Tan N; Toh JZN; Abbott JE; Usai C; Ooi EE; Low JGH; Le Bert N; Kennedy PTF; Bertoletti A
Med; 2022 Feb; 3(2):104-118.e4. PubMed ID: 35072129
[TBL] [Abstract][Full Text] [Related]
17. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.
Citu IM; Citu C; Gorun F; Sas I; Tomescu L; Neamtu R; Motoc A; Gorun OM; Burlea B; Bratosin F; Malita D
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215900
[TBL] [Abstract][Full Text] [Related]
19. Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Abedon AT; Teles MS; Alejo JL; Kim JD; Mitchell J; Chiang TPY; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
Transplantation; 2022 May; 106(5):e262-e263. PubMed ID: 35175241
[TBL] [Abstract][Full Text] [Related]
20. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
